Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Cardiomyopathies are defined as disorders of heart muscle unexplained by coronary artery disease, hypertension, valvular disease or congenital heart disease.1 They are classified by morphological and functional phenotype into hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), restrictive cardiomyopathy (RCM), and arrhythmogenic right ventricular cardiomyopathy (ARVC) subtypes.1 Table 1 shows the European Society of Cardiology working group classification of cardiomyopathies.
- In this window
- In a new window
All forms of cardiomyopathy can be caused by genetic and non-genetic mechanisms. The first genetic locus associated with HCM was discovered by linkage analysis2 in 1989 and the responsible gene, β-myosin heavy chain (MYH7), was identified in the subsequent year.w1 Since then, extraordinary progress has been made in the understanding of the molecular genetic background of all inherited heart muscle disorders.3 w2 Most genetic forms of cardiomyopathy are inherited as autosomal dominant Mendelian diseases and are characterised by locus and allelic genetic heterogeneity, highly variable intra- and interfamilial expressivity, and incomplete clinical penetrance.1 ,4 This very high level of genotype–phenotype plasticity may result from the influence of modifier genes, epigenetic effects, post-transcriptional and post-translational modifications, and environmental effects.5 ,6
The genetic and phenotypic heterogeneity that characterises all cardiomyopathies pose major clinical challenges. In this article, we focus on the task of diagnosis, exploring how a systematic clinical approach can be used to identify specific disorders and guide the selection of further diagnostic tests, including molecular genetic analysis. The basic premise is that a cardiomyopathy focused approach to history and examination combined with conventional and emerging diagnostic tests can be used to identify clues or ‘red flags’ that suggest particular genetic and non-genetic sub-phenotypes (figure 1).
While a brief enquiry …
Contributors Both authors have contributed to the writing of this review article and are responsible for the overall content.
Funding LRL is supported by a grant from the Gulbenkian Doctoral Programme for Advanced Medical Education, sponsored by Fundação Calouste Gulbenkian, Fundação Champalimaud, Ministério da Saúde and Fundação para a Ciência e Tecnologia, Portugal.
Competing interests In compliance with EBAC/EACCME guidelines, all authors participating in Education in Heart have disclosed potential conflicts of interest that might cause a bias in the article. The authors have no competing interests.
Provenance and peer review Commissioned; internally peer reviewed.